MyFinsight
Home
Blog
About
Marketable securities,
current
$208,444K
Cash and cash
equivalents
$202,643K
(-23.40%↓ Y/Y)
Prepaid expenses and
other current assets
$9,336K
(41.26%↑ Y/Y)
Total current assets
$420,423K
(55.05%↑ Y/Y)
Marketable securities,
non-current
$83,821K
Operating lease
right-of-use asset
$18,442K
(-15.04%↓ Y/Y)
Property and equipment,
net
$4,391K
(-26.89%↓ Y/Y)
Other assets
$3,460K
(-3.00%↓ Y/Y)
Restricted cash
$1,088K
(-0.09%↓ Y/Y)
Total assets
$531,625K
(75.15%↑ Y/Y)
Total liabilities and
stockholders' equity
$531,625K
(75.15%↑ Y/Y)
Total stockholders'
equity
$453,124K
(72.79%↑ Y/Y)
Total liabilities
$78,501K
(90.16%↑ Y/Y)
Accumulated deficit
-$558,482K
(-31.44%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$435K
Additional
paid-in-capital
$1,011,985K
(47.29%↑ Y/Y)
Term loan,
non-current
$38,960K
Total current
liabilities
$22,961K
(15.38%↑ Y/Y)
Operating lease
liabilities, net of current...
$16,580K
(-18.29%↓ Y/Y)
Common stock, 0.001 par
value 500,000,000...
$56K
(27.27%↑ Y/Y)
Accrued expenses and
other current...
$15,866K
(37.77%↑ Y/Y)
Operating lease
liabilities, current
$4,883K
(3.50%↑ Y/Y)
Accounts payable
$2,212K
(-39.66%↓ Y/Y)
Back
Back
Balance Sheet
Maze Therapeutics, Inc. (MAZE)
Maze Therapeutics, Inc. (MAZE)
source: myfinsight.com